  Manufacturers of vaccines used to prevent potential avian  pandemics will receive immunity from product liability claims, HHS announced on  January 1. 

The move, which triggers a provision of the Public Readiness  and Emergency Preparedness Act passed in late 2005, would grant protection from  such claims for parties involved in the preparation of reference strains and  the development, manufacturing, testing, and administration of vaccines. 

The notice said that the liability was granted “to encourage  the design, development, clinical testing or investigation” of countermeasures,  based on the “credible risk” that that an avian influenza outbreak could spread  to humans. 

News

Manufacturers of vaccines used to prevent potential avian pandemics will receive immunity from product liability claims, HHS announced on January 1.